[Bacteriological profile and antibiotic treatment of postoperative peritonitis].

K Missaoui, Y Marzougui, J Kouka, Y Dhibi, Z Hannachi, C Dziri, M Houissa
{"title":"[Bacteriological profile and antibiotic treatment of postoperative peritonitis].","authors":"K Missaoui,&nbsp;Y Marzougui,&nbsp;J Kouka,&nbsp;Y Dhibi,&nbsp;Z Hannachi,&nbsp;C Dziri,&nbsp;M Houissa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>During the postoperative peritonitis (PPO) the main stay of treatment is the choice of probabilistic antibiotictherapy, it is also the main prognostic factor The aim of our study was to identify anappropriate antibiotic protocol to the current ecology of our unit. It was a retrospective study including 102 patients over a period of 09 years from 1 January 2003 to 3O November 2011. All of them are supported for the treatments off postoperative peritonitis in surgical intensive care unit of a service of general surgery a university hospital Charles Nicolle of Tunis. All bacteriological data (germs and sensitivity), and the terms of therapeutic modality for the empirical antibiotic therapy were listed. The incidence of PPO was Q90%.The average age of our patients was 57 +/- 18 years. The sex ratio was 1.08. One hundred and seven (107) microorganisms were isolated from 72 samples (44 microbial mono, 28 multi microbial). The frequency of gram-positive cocci (GPC) was 16.82%, the Gram-negative bacilli (BGN) was 82.2%. The Enterobacteriaceae have proved particularity resistant. Thus, the ampicillin resistance was 87.14%, that the C3G was 33.80%, the Piperacillin to Tazobactam combination, was 36.5% and that the association Ticarcillin-clavulanic acid was 43.6%. For non-fermenting BGN, Pseudomonas aeruginosa was sensitive to ticarcillin in 80% of cases, to ceftazidime in 66.6% of cases, PiperacillinTazobactam--in 71.43% of cases, imipenem in 85 72% of cases, colimycin in 100% of cases and Amiklin in 71.43% of cases. For CGP, enterococci were resistant to ampicillin in 50% of cases and vancomycin in 0% of cases. The majority of patients received triple antibiotic therapy (59.8%) or combination therapy (34.3%). The main associations were: cefotaxime + Gentamycin + Metronidazole (35.2%), Amikacin Imipenem + + Metronidazole (12.7%), Imipenem + amikacin (9.8%), Piperacillin / Tazobactam + amikacin (9.8%) + amikacin and ertapenem (5.88%). Probabilitic antibiotic therapy was addapted in 69.4% of cases. The average duration of the prescribed antibiotic was 11 days +/- 6 days. The mortality rate was 39.2%, was 32.23 days. The isolated microorganisms are those of the intestinal flora which is generally changed and thus the bacteria are selected then are multidrug resistant. Prescribing antibiotics should consider probabilistic. Thus, Imipenem-Amiklin combination seems appropriate to our ecology. This empiric antibiotic therapy is secondarily adapted to the results of susceptibility testing to limit the selection of multi-resistant organisms.</p>","PeriodicalId":75537,"journal":{"name":"Archives de l'Institut Pasteur de Tunis","volume":"91 1-4","pages":"57-66"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives de l'Institut Pasteur de Tunis","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

During the postoperative peritonitis (PPO) the main stay of treatment is the choice of probabilistic antibiotictherapy, it is also the main prognostic factor The aim of our study was to identify anappropriate antibiotic protocol to the current ecology of our unit. It was a retrospective study including 102 patients over a period of 09 years from 1 January 2003 to 3O November 2011. All of them are supported for the treatments off postoperative peritonitis in surgical intensive care unit of a service of general surgery a university hospital Charles Nicolle of Tunis. All bacteriological data (germs and sensitivity), and the terms of therapeutic modality for the empirical antibiotic therapy were listed. The incidence of PPO was Q90%.The average age of our patients was 57 +/- 18 years. The sex ratio was 1.08. One hundred and seven (107) microorganisms were isolated from 72 samples (44 microbial mono, 28 multi microbial). The frequency of gram-positive cocci (GPC) was 16.82%, the Gram-negative bacilli (BGN) was 82.2%. The Enterobacteriaceae have proved particularity resistant. Thus, the ampicillin resistance was 87.14%, that the C3G was 33.80%, the Piperacillin to Tazobactam combination, was 36.5% and that the association Ticarcillin-clavulanic acid was 43.6%. For non-fermenting BGN, Pseudomonas aeruginosa was sensitive to ticarcillin in 80% of cases, to ceftazidime in 66.6% of cases, PiperacillinTazobactam--in 71.43% of cases, imipenem in 85 72% of cases, colimycin in 100% of cases and Amiklin in 71.43% of cases. For CGP, enterococci were resistant to ampicillin in 50% of cases and vancomycin in 0% of cases. The majority of patients received triple antibiotic therapy (59.8%) or combination therapy (34.3%). The main associations were: cefotaxime + Gentamycin + Metronidazole (35.2%), Amikacin Imipenem + + Metronidazole (12.7%), Imipenem + amikacin (9.8%), Piperacillin / Tazobactam + amikacin (9.8%) + amikacin and ertapenem (5.88%). Probabilitic antibiotic therapy was addapted in 69.4% of cases. The average duration of the prescribed antibiotic was 11 days +/- 6 days. The mortality rate was 39.2%, was 32.23 days. The isolated microorganisms are those of the intestinal flora which is generally changed and thus the bacteria are selected then are multidrug resistant. Prescribing antibiotics should consider probabilistic. Thus, Imipenem-Amiklin combination seems appropriate to our ecology. This empiric antibiotic therapy is secondarily adapted to the results of susceptibility testing to limit the selection of multi-resistant organisms.

[术后腹膜炎的细菌学概况及抗生素治疗]。
在术后腹膜炎(PPO)治疗的主要问题是选择概率抗生素治疗,这也是主要的预后因素。我们研究的目的是确定一种适合我们单位当前生态的抗生素方案。这是一项回顾性研究,包括102例患者,时间为2003年1月1日至2011年11月30日,历时09年。所有这些人都在突尼斯Charles Nicolle大学医院普通外科服务的外科重症监护室接受术后腹膜炎的治疗。列出了所有细菌学数据(细菌和敏感性),以及经验性抗生素治疗的治疗方式。PPO的发生率为90%。患者的平均年龄为57±18岁。性别比为1.08。从72份样品中分离到107个微生物(单微生物44个,多微生物28个)。革兰阳性球菌(GPC)检出率为16.82%,革兰阴性杆菌(BGN)检出率为82.2%。肠杆菌科已被证明具有特别的抵抗力。氨苄西林耐药率为87.14%,C3G耐药率为33.80%,哌拉西林与他唑巴坦联用耐药率为36.5%,替卡西林-克拉维酸联用耐药率为43.6%。对于非发酵BGN,铜绿假单胞菌对替卡西林敏感的占80%,对头孢他啶敏感的占66.6%,对哌拉西林他唑巴坦敏感的占71.43%,对亚胺培南敏感的占85.72%,对高霉素敏感的占100%,对阿米克林敏感的占71.43%。对于CGP,肠球菌对氨苄西林和万古霉素的耐药率分别为50%和0%。大多数患者接受三联抗生素治疗(59.8%)或联合治疗(34.3%)。主要相关性为:头孢噻肟+庆大霉素+甲硝唑(35.2%)、阿米卡星-亚胺培南+甲硝唑(12.7%)、亚胺培南+阿米卡星(9.8%)、哌拉西林/他唑巴坦+阿米卡星(9.8%)+阿米卡星和厄他培南(5.88%)。69.4%的病例采用了概率性抗生素治疗。处方抗生素的平均持续时间为11天+/- 6天。死亡率为39.2%,为32.23 d。所分离的微生物是肠道菌群的微生物,这些菌群通常发生变化,因此选择了具有多重耐药的细菌。开抗生素处方应考虑概率。因此,亚胺培南-阿米克林组合似乎适合我们的生态环境。这种经验性抗生素治疗是根据药敏试验的结果进行二次调整,以限制多重耐药菌的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信